KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis.
Serum levels of KL-6 were examined in 8 cases of juvenile dermatomyositis: 3 with interstitial lung disease (ILD) and 5 without ILD. The KL-6 levels were elevated in the ILD cases and correlated with the degree of computed tomography findings. The measurement of serum KL-6 levels is useful for evaluating juvenile dermatomyositis-associated ILD.
Kobayashi
I
I
Departments of Pediatrics and Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Ono
S
S
Kawamura
N
N
Okano
M
M
Miyazawa
K
K
Shibuya
H
H
Kobayashi
K
K
D000941:Antigens / Q000097:blood*; D000951:Antigens, Neoplasm; D015415:Biomarkers / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D003882:Dermatomyositis / Q000097:blood / Q000150:complications*; D005260:Female; D006023:Glycoproteins / Q000097:blood*; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000097:blood / Q000150:complications*; D008297:Male; D018396:Mucin-1; D009077:Mucins
D000941:Antigens; D000951:Antigens, Neoplasm; D015415:Biomarkers; D006023:Glycoproteins; C060192:MUC1 protein, human; D018396:Mucin-1; D009077:Mucins